PAN3 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.75259806667327E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.24989999981263E-07 |
Normal-vs-Stage2 |
4.977900E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.415600E-04 |
Stage1-vs-Stage2 |
4.199600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
1.090780E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.401000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.92920132594077E-11 |
Normal-vs-AfricanAmerican |
9.096400E-02 |
Normal-vs-Asian |
1.24020000047409E-07 |
Caucasian-vs-AfricanAmerican |
6.207500E-02 |
Caucasian-vs-Asian |
5.764600E-01 |
AfricanAmerican-vs-Asian |
8.965900E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.10269999995272E-06 |
Normal-vs-Female |
6.46029996165254E-09 |
Male-vs-Female |
2.487600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.378800E-04 |
Normal-vs-Extreme_Weight |
1.26720000004354E-06 |
Normal-vs-Obese |
9.584800E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
8.140400E-01 |
Normal_Weight-vs-Obese |
2.876000E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
3.380800E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.124400E-01 |
Normal-vs-Age(41-60Yrs) |
2.803600E-04 |
Normal-vs-Age(61-80Yrs) |
2.70620004183542E-09 |
Normal-vs-Age(81-100Yrs) |
4.876400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.506600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.271200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.231400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.448800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.791800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.488150E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.505600E-01 |
Normal-vs-Grade 3 |
9.995000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
4.208400E-01 |
Grade 2-vs-Grade 4 |
7.505600E-01 |
Grade 3-vs-Grade 4 |
9.995000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.5751000503883E-09 |
Normal-vs-N1 |
3.971200E-04 |
N0-vs-N1 |
3.396200E-02 |
|
|